Migraine Drugs Market Size, Share & Trends Report

Migraine Drugs Market Size, Share & Trends Analysis Report By Treatment (Acute, Preventive), By Therapeutic Class, By Route Of Administration, By Age Group (Pediatric, Adult, Geriatric), By Availability, By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-2-68038-559-5
Number of Report Pages: 159
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Migraine Drugs Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Acute
- Preventive
Migraine Drugs Therapeutic Class Outlook (Revenue, USD Million, 2018 - 2030)
- CGRP monoclonal antibodies
- CGRP small molecule antagonists
- Acetylcholine inhibitors/ neurotoxins
- Triptans
- Ditans
- Ergot alkaloids
- NSAIDs
- Others
Migraine Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Injectable
- Others
Migraine Drugs Age Group Outlook (Revenue, USD Million, 2018 - 2030)
- Pediatric
- Adult
- Geriatric
Migraine Drugs Availability Outlook (Revenue, USD Million, 2018 - 2030)
- Prescription Drugs
- Over-the-Counter (OTC) Drugs
Migraine Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Migraine Drugs Market, By Treatment
    - Acute
    - Preventive
  - North America Migraine Drugs Market, By Application
    - CGRP monoclonal antibodies
    - CGRP small molecule antagonists
    - Acetylcholine inhibitors/ neurotoxins
    - Triptans
    - Ditans
    - Ergot alkaloids
    - NSAIDs
    - Others
  - North America Migraine Drugs Market, By Route of Administration
    - Oral
    - Injectable
    - Others
  - North America Migraine Drugs Market, By Age Group
    - Pediatric
    - Adult
    - Geriatric
  - North America Migraine Drugs Market, By Availability
    - Prescription Drugs
    - Over-the-Counter (OTC) Drugs
  - U.S.
    - U.S. Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - U.S. Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - U.S. Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - U.S. Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - U.S. Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Canada
    - Canada Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Canada Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Canada Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Canada Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Canada Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Mexico
    - Mexico Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Mexico Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Mexico Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Mexico Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Mexico Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
- Europe
  - Europe Migraine Drugs Market, By Treatment
    - Acute
    - Preventive
  - Europe Migraine Drugs Market, By Application
    - CGRP monoclonal antibodies
    - CGRP small molecule antagonists
    - Acetylcholine inhibitors/ neurotoxins
    - Triptans
    - Ditans
    - Ergot alkaloids
    - NSAIDs
    - Others
  - Europe Migraine Drugs Market, By Route of Administration
    - Oral
    - Injectable
  - Europe Migraine Drugs Market, By Age Group
    - Pediatric
    - Adult
    - Geriatric
  - Europe Migraine Drugs Market, By Availability
    - Prescription Drugs
    - Over-the-Counter (OTC) Drugs
  - UK
    - UK Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - UK Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - UK Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - UK Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - UK Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Germany
    - Germany Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Germany Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Germany Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Germany Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Germany Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - France
    - France Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - France Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - France Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - France Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - France Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Italy
    - Italy Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Italy Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Italy Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Italy Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Italy Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Spain
    - Spain Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Spain Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Spain Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Spain Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Spain Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Denmark
    - Denmark Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Denmark Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Denmark Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Denmark Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Denmark Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Sweden
    - Sweden Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Sweden Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Sweden Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Sweden Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Sweden Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Norway
    - Norway Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Norway Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Norway Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Norway Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Norway Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
- Asia Pacific
  - Asia Pacific Migraine Drugs Market, By Treatment
    - Acute
    - Preventive
  - Asia Pacific Migraine Drugs Market, By Application
    - CGRP monoclonal antibodies
    - CGRP small molecule antagonists
    - Acetylcholine inhibitors/ neurotoxins
    - Triptans
    - Ditans
    - Ergot alkaloids
    - NSAIDs
    - Others
  - Asia Pacific Migraine Drugs Market, By Route of Administration
    - Oral
    - Injectable
    - Others
  - Asia Pacific Migraine Drugs Market, By Age Group
    - Pediatric
    - Adult
    - Geriatric
  - Asia Pacific Migraine Drugs Market, By Availability
    - Prescription Drugs
    - Over-the-Counter (OTC) Drugs
  - Japan
    - Japan Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Japan Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Japan Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Japan Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Japan Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - China
    - China Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - China Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - China Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - China Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - China Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - India
    - India Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - India Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - India Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - India Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - India Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - South Korea
    - South Korea Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - South Korea Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - South Korea Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - South Korea Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - South Korea Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Australia
    - Australia Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Australia Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Australia Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Australia Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Australia Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Thailand
    - Thailand Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Thailand Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Thailand Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Thailand Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Thailand Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
- Latin America
  - Latin America Migraine Drugs Market, By Treatment
    - Acute
    - Preventive
  - Latin America Migraine Drugs Market, By Application
    - CGRP monoclonal antibodies
    - CGRP small molecule antagonists
    - Acetylcholine inhibitors/ neurotoxins
    - Triptans
    - Ditans
    - Ergot alkaloids
    - NSAIDs
    - Others
  - Latin America Migraine Drugs Market, By Route of Administration
    - Oral
    - Injectable
    - Others
  - Latin America Migraine Drugs Market, By Age Group
    - Pediatric
    - Adult
    - Geriatric
  - Latin America Migraine Drugs Market, By Availability
    - Prescription Drugs
    - Over-the-Counter (OTC) Drugs
  - Brazil
    - Brazil Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Brazil Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Brazil Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Brazil Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Brazil Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Argentina
    - Argentina Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Argentina Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Argentina Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Argentina Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Argentina Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
- MEA
  - MEA Migraine Drugs Market, By Treatment
    - Acute
    - Preventive
  - MEA Migraine Drugs Market, By Application
    - CGRP monoclonal antibodies
    - CGRP small molecule antagonists
    - Acetylcholine inhibitors/ neurotoxins
    - Triptans
    - Ditans
    - Ergot alkaloids
    - NSAIDs
    - Others
  - MEA Migraine Drugs Market, By Route of Administration
    - Oral
    - Injectable
    - Others
  - MEA Migraine Drugs Market, By Age Group
    - Pediatric
    - Adult
    - Geriatric
  - MEA Migraine Drugs Market, By Availability
    - Prescription Drugs
    - Over-the-Counter (OTC) Drugs
  - South Africa
    - South Africa Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - South Africa Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - South Africa Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - South Africa Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - South Africa Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Saudi Arabia
    - Saudi Arabia Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Saudi Arabia Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Saudi Arabia Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Saudi Arabia Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Saudi Arabia Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - UAE
    - UAE Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - UAE Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - UAE Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - UAE Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - UAE Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs
  - Kuwait
    - Kuwait Migraine Drugs Market, By Treatment
      - Acute
      - Preventive
    - Kuwait Migraine Drugs Market, By Therapeutic Class
      - CGRP monoclonal antibodies
      - CGRP small molecule antagonists
      - Acetylcholine inhibitors/ neurotoxins
      - Triptans
      - Ditans
      - Ergot alkaloids
      - NSAIDs
      - Others
    - Kuwait Migraine Drugs Market, By Route of Administration
      - Oral
      - Injectable
      - Others
    - Kuwait Migraine Drugs Market, By Age Group
      - Pediatric
      - Adult
      - Geriatric
    - Kuwait Migraine Drugs Market, By Availability
      - Prescription Drugs
      - Over-the-Counter (OTC) Drugs

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.